DEF: CeriBell Sets June 2, 2026 Annual Meeting Date

CeriBell, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 2, 2026, to elect directors and ratify auditor appointment.

Summary

• CeriBell, Inc. is holding its 2026 Annual Meeting of Stockholders virtually on June 2, 2026, at 9:00 a.m. Pacific Time.
• The meeting agenda includes the election of two director nominees and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026.
• The record date for determining stockholders eligible to vote is April 6, 2026.
• The Board of Directors recommends voting FOR the election of the director nominees and FOR the ratification of the independent auditor.
• Proxy materials are being made available online, with a Notice of Internet Availability to be mailed around April 20, 2026.
• The company is an emerging growth company and is complying with reduced public company reporting requirements.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it confirms routine governance procedures are in place and highlights the experience of board members, but contains no new financial or strategic information.

Positives

• The company is holding its annual meeting as scheduled, indicating ongoing operational and governance processes.
• The Board of Directors is actively seeking stockholder input through the voting process.
• PricewaterhouseCoopers LLP, a reputable accounting firm, is proposed for continued service, suggesting auditor confidence.
• The company has a clear process for stockholder proposals and director nominations for future meetings.

Negatives

• Several Section 16(a) reports were filed late in 2025, indicating minor administrative lapses in compliance for certain directors and officers.
• The company's status as an emerging growth company means reduced executive compensation disclosures and no non-binding advisory votes on executive compensation.

Risks

• Potential for broker non-votes on the election of directors, as it is considered a non-routine matter.
• The company's reliance on its current leadership team and board structure, with potential risks if key individuals depart or face challenges.
• The company's status as an emerging growth company may limit certain disclosures and stockholder oversight mechanisms.

Future Outlook

The filing primarily concerns the upcoming annual meeting and does not contain specific forward-looking financial guidance. It outlines the process for future stockholder proposals and director nominations.

Management Comments

• "The Notice of Annual Meeting of Stockholders and the Proxy Statement contain details of the business to be conducted at the Annual Meeting."
• "Whether or not you attend the Annual Meeting online, it is important that your shares be represented and voted at the Annual Meeting. Therefore, I urge you to promptly vote and submit your proxy via the Internet, by phone, or by mail."
• "On behalf of the Board of Directors, I would like to express our appreciation for your interest in CeriBell, Inc."
• "We believe that stockholder ratification is a good corporate governance practice."

Industry Context

StockSavvy.ai notes that this filing is typical for a publicly traded company preparing for its annual shareholder meeting, focusing on routine governance matters like director elections and auditor ratification. The company's status as an 'emerging growth company' aligns with trends of smaller, newer public companies leveraging regulatory flexibility.

Management Changes

Corporate Governance

Related Party Transactions

• Consulting agreement with Dr. Josef Parvizi, Chief Medical Advisor, for medical and scientific guidance. Dr. Parvizi was paid $202,525 in 2025 and $192,450 in 2024 for these services. His compensation is $450 per hour, capped at 36 hours per month, with reimbursement for approved expenses.

Stakeholder Impact

• Shareholders: Will vote on director elections and auditor ratification, influencing board composition and oversight. Their ability to receive separate proxy materials is addressed.
• Directors and Officers: Subject to late Section 16(a) filings, indicating a need for improved compliance processes. Their compensation and equity awards are detailed.
• Independent Auditor (PwC): Seeking ratification for continued services, impacting financial reporting and audit oversight.

Next Steps

• Stockholders to vote on the election of director nominees and the ratification of the independent auditor.
• The company will file a Current Report on Form 8-K within four business days after the Annual Meeting to announce voting results.

Key Dates

Recommendation

This filing is a routine proxy statement for an annual meeting and does not contain new financial performance data, strategic shifts, or significant risk disclosures that would warrant a change in investment recommendation. It confirms ongoing governance processes and board composition.

Keywords

CeriBell, DEF 14A, Proxy Statement, Annual Meeting, Stockholders, Director Election, Independent Auditor, PricewaterhouseCoopers LLP, Corporate Governance, Emerging Growth Company